野村控股
NMR
9.24
-0.04
-0.43%
野村控股
US · NMR
#706 按市值排名
上市于 1970
9.24
-0.04
-0.43%
实时 - 追踪5344个代码 - 心跳于395秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期(2026/Q3)披露持股的机构数量减少了4家。
- 机构持股总比例下降了0.7个百分点。
机构持股
- 机构持股比例
- 49.83% -0.67pp
- 机构数量
- 531 -4
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund40.02%
Public Company4.01%
Hedge Fund2.27%
Sovereign Wealth Fund1.47%
Private Company1.07%
Government Pension Fund0.74%
Insurance Company0.19%
Individual/Insider0.12%
Other50.06%
主要股东 截至 2026-06-30
BlackRock
9.49% · 277.37M 股
Nomura Asset Management
4.69% · 137.09M 股
Vanguard Capital Management, LLC
3.86% · 112.76M 股
Sumitomo Mitsui Trust Asset Management
3.18% · 93.09M 股
Amova Asset Management
2.15% · 62.77M 股
Daiwa Asset Management
1.96% · 57.34M 股
Man Group Plc
1.93% · 56.52M 股
Sumitomo Mitsui Financial Group, Inc.
1.62% · 47.29M 股
Norges Bank Investment Management
1.47% · 43.04M 股
Mitsubishi UFJ Asset Management
1.44% · 42.12M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 49次买入 · 0次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Yutaka Nakajima | Representative Executive Officer and Deputy President & Head of Global Markets and Director | 0.02% |
| Kentaro Okuda | President, Group CEO, Representative Executive Officer & Director | 0.02% |
| Koji Nagai | Chairperson | 0.02% |
| Toshiyasu Iiyama | Chief of Staff, Executive Officer & Deputy President | 0.01% |
| Masahiro Goto | Senior MD & Global Head of Investment Banking | 0.01% |
| Shinichi Okada | Senior Managing Director of Banking | 0.01% |
| Takumi Kitamura | Executive Officer, CFO & Investor Relations | 0.00% |
| Hiroyasu Koike | Senior MD & Head of Investment Management | 0.00% |
| Akihito Tobari | Executive Vice President | 0.00% |
| Yoshihiro Namura | Senior MD & Head of Investment Management-Investment Products and Advisory Solutions | 0.00% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-24 | Hiroyasu Koike | Senior MD & Head of Investment Management | Other Acquisition | +247 | $9.97 |
| 2026-09-24 | Shoji Ogawa | Non-Executive Director | Other Acquisition | +185 | $9.97 |
| 2026-09-24 | Yukiko Ozaki | Senior MD, Chief Human Resources Officer & Chief Health Officer | Other Acquisition | +6 | $9.97 |
| 2026-09-24 | Akihito Tobari | Executive Vice President | Other Acquisition | +61 | $9.97 |
| 2026-09-24 | Akio Hori | Senior Managing Director of Group IT | Other Acquisition | +61 | $9.97 |
| 2026-09-24 | Masahiro Ishizuka | Independent Outside Director | Other Acquisition | +185 | $9.97 |
| 2026-08-24 | Hiroyasu Koike | Senior MD & Head of Investment Management | Other Acquisition | +261 | $9.87 |
| 2026-08-24 | Shoji Ogawa | Non-Executive Director | Other Acquisition | +196 | $9.87 |
| 2026-08-24 | Yukiko Ozaki | Senior MD, Chief Human Resources Officer & Chief Health Officer | Other Acquisition | +6 | $9.87 |
| 2026-08-24 | Akihito Tobari | Executive Vice President | Other Acquisition | +65 | $9.87 |
| 2026-08-24 | Akio Hori | Senior Managing Director of Group IT | Other Acquisition | +65 | $9.87 |
| 2026-08-24 | Masahiro Ishizuka | Independent Outside Director | Other Acquisition | +196 | $9.87 |
| 2026-07-23 | Hiroyasu Koike | Senior MD & Head of Investment Management | Other Acquisition | +245 | $9.83 |
| 2026-07-23 | Shoji Ogawa | Non-Executive Director | Other Acquisition | +183 | $9.83 |
| 2026-07-23 | Yukiko Ozaki | Senior MD, Chief Human Resources Officer & Chief Health Officer | Other Acquisition | +6 | $9.83 |
| 2026-07-23 | Akihito Tobari | Executive Vice President | Other Acquisition | +61 | $9.83 |
| 2026-07-23 | Akio Hori | Senior Managing Director of Group IT | Other Acquisition | +61 | $9.83 |
| 2026-07-23 | Masahiro Ishizuka | Independent Outside Director | Other Acquisition | +183 | $9.83 |
| 2026-06-24 | Koji Nagai | Chairperson | Other Acquisition | 0 | $8.86 |
| 2026-06-24 | Hiroyasu Koike | Senior MD & Head of Investment Management | Other Acquisition | +273 | $8.86 |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
野村控股 讨论区 0 条评论